Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes
Status:
Completed
Trial end date:
2003-11-10
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia. The aim of this trial is to investigate the efficacy of
blood glucose control with combination therapy of repaglinide and metformin compared to
conventional treatment with a sulphonylurea or metformin in monotherapy in type 2 diabetes